Abstract
Background: The identification of novel molecular mechanisms for cardiac hypertrophy is of considerable interest.
Results: Cardiomyocyte-specific knockout of KLF4 enhanced-adrenoreceptor agonist-induced cardiac hypertrophy by modulating myocardin expression and activity.
Conclusion: KLF4 is a novel regulator of cardiac hypertrophy.
Significance: Control of KLF4 is a potential therapeutic target for cardiac hypertrophy.
Original language | English |
---|---|
Pages (from-to) | 26107-26118 |
Number of pages | 12 |
Journal | Journal of Biological Chemistry |
Volume | 289 |
Issue number | 38 |
DOIs | |
Publication status | Published - 2014 Sept 19 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology